chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mild asthma attack; moderate dyspnea; chest pressure; a 4-5 cm area of induration; mild erythema in her left deltoid area; This is a spontaneous report from a contactable physician.  A non-pregnant 37-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: Unknown), intramuscularly in the left arm on 19Dec2020 at 37-years-old at a SINGLE DOSE for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history included intermittent asthma from an unknown date and unknown if ongoing. Concomitant medications were not reported.  The patient experienced the following events and outcomes: mild asthma attack on 21Dec2020 with outcome of recovering, moderate dyspnea on 21Dec2020 with outcome of recovering, chest pressure on 21Dec2020 with outcome of recovering, a 4-5 cm area of induration in Dec2020 with outcome of unknown, mild erythema in her left deltoid area in Dec2020 with outcome of unknown. The patient had intermittent asthma with no attacks in the past six years. Two days after the vaccination, she had a mild asthma attack when she was walking up stairs. For the past two days, she has had multiple asthma attacks, with moderate dyspnea and chest pressure present for most of the day. The patient's symptoms have been improving with her as needed (PRN) salbutamol (ALBUTEROL) inhaler. The physician saw the patient in a telemedicine visit and found her to have an asthma exacerbation; therefore, prednisone was prescribed. The patient had no symptoms of viral infection and reported testing negative for COVID-19 after the onset of her asthma symptoms. The physician suspected her asthma exacerbation to have been caused by the vaccine because she had been symptom-free in recent years and she has not had a new exposure other than the vaccine. In addition to her respiratory symptoms, the patient had a 4-5 cm area of induration and mild erythema in her left deltoid area; this appeared about 1 week after she received the vaccine. Therapeutic measures were taken as a result of mild asthma attack, moderate dyspnea, chest pressure. The patient, since the vaccination, had been tested for COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.
Pt went to pharmacy near her college seeking 2nd Mening B vaccine. Was given TRUMENBA. Got BEXSERO as 1st dose. Pt. advised to finish series after 2-15-17 with TRUMENBA.
While sitting in the waiting area I began to feel itchy. it was around 7:50am. I quickly took 2 chewable (12.5mg each) benadryl tablets. after about 5 min. i felt stable enough to leave. on the way home I started to  feel the itching intensify and I felt very warm. I had welts forming and hives appeared all over. As I pulled into my driveway( 7 min drive from vaccination site) I felt my lips and eyelids swell, and my throat felt tingly. I took another 2 chewable benadryls. (12.5mg each). I immediately called my Doctor and explained what was going on. I also started to wheeze. I used my inhaler.  He told me to use my epipen. Which I already had prepared since I knew this was anaphylaxis. I started to feel stable enough to go inside. I called my husband to come downstairs to be with me. I still wasnt feeling well and the tightness and wheezing persisted. At around  8:40, My dr. told me to use the 2nd Epipen and use my nebulaizer.  If I wasn't better in 10 minutes he would call an ambulance. Thank GD the itching and hives subsided and the wheezing and tightness diminished by aroung 8:50am. My dr. comtinued to monitor me and check up on me. By 3pm I was back to myself.
Pediarix was given in error instead of the 4 year old booster DTAP that was suppose to be given along with his 4 year old booster vaccine Polio. Mom contacted on day of vaccine 8/11/08 and then f/u on 8/18/08. Mom reported that Arian  had a fever the evening of 8/11 for about 4 hours that was relieved by Tylenol.
Moderna COVID-19 Vaccine EUA   Within first 15 minutes after vaccination, patient experienced flushing of the left arm.  Within 1 hour patient experienced feverish feelings, rapid pulse, transient nausea and then hives/blistering on the left neck arm and back.  Patient took Benadryl and Zyrtec daily times 2 days following vaccination.
Engerix-B was administered 4 days after the expiration date; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 5-day-old female patient who received HBV (Engerix B) (batch number LP724, expiry date 18-MAY-2023) for prophylaxis.   On 22-MAY-2023, the patient received the 1st dose of Engerix B. On 22-MAY-2023, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Engerix-B was administered 4 days after the expiration date). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 22-MAY-2023 Medical Assistant Supervisor stated that Engerix-B was administered 4 days after the expiration date. Consented to follow up via postal.
On 10/1 I developed an occlusion of left ulnar artery and partial occlusion of left radial artery.  I presented to the ER with an ischemic index finger and thumb.  Diagnosis was made by CTA. Per vascular surgery I was on a heparin drip overnight. The next morning circulation was documented via doppler and I was discharged on plavix, xerelto, and nifedipine. It is now one week out and I am still being treated. The thought is vasculitis and vasospasm and not thrombosis but they aren't sure.
6 weeks after administration of COVID-19 vaccine developed DVT in right subclavian vein which progressed to a subsegmental PE 2 days after confirmation by ultrasound despite being on Eliquis.
Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Near syncopal event immediately after injection, pt was assisted to lye down with feet up and observed in clinic for 30 minutes. Pt. recovered without issue and was ambulatory and reported feeling better upon leaving clinic. BP was 100/70, heart rate 80.
SHORTNESS OF BREATH; FLUSHED FACE; FEELING OF SOMETHING STUCK IN THROAT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-MAY-2021 11:00 for prophylactic vaccination. The batch number was not reported and has been request. No concomitant medications were reported. On 09-MAY-2021, the subject experienced shortness of breath. On 09-MAY-2021, the subject experienced flushed face. On 09-MAY-2021, the subject experienced feeling of something stuck in throat. Laboratory data included: Oxygen saturation (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the shortness of breath, flushed face and feeling of something stuck in throat was not reported. This report was non-serious.
Swelling, Redness, itching at injection site. Antihistamines for treatment.
Fever or Chills; Cough; Fatigue; Muscle or body aches; Headache.; Congestion or running nose.
My mom who is 75 had an adverse reaction on from the COVID vaccine she took on Jan 15, 2021. She went to bed at night and woke up at 4 AM with a severe headache. She took Aleve and went back to bed. When she woke up at 8:30 AM her headache was very severe and was accompanied with very severe chest pain. I immediately took her to the ER. They did a very thorough work up to check on her heart and Aorta. They managed her severe pain with two doses of morphine followed by two days of Dilaudid. The imaging and symptoms left her with a newly discovered diagnosis of Pericarditis. The medical professions were sure this was a result of the COVID vaccine. They continued to treat her for a few days and sent her home with anti inflammatories to help. She continues to have muscle pain, weakness and shortness of breath when she walks. She is scheduled to take her 2nd dose on February 5th but we are very concerned and hesitant as we don't want to cause any more damage to her heart. Please have somebody contact us and let us know how to proceed. Thanks.
Jansen COVID-19 Vaccine EUA   ENDED UP IN ER ON 4/4/2021 due to severe allergic reaction at injection sight and unbearable pain. Discovered by doctors that a nerve was hit at injection sight and that the shot was done too low in my arm.  Very hot to touch and swelling as well.
Pt mother reported fever, decreased appetite, decreased urinary output and irritability to our office on 8/9/19. She notes that the symptoms started on 8/7/19. She was referred to the ER the same day to Hospital on 8/9/19. She was then transferred to other due to seizures and the diagnosis of pneumococcal meningitis. Patient is still admitted there. It was recommended per the PA Department of Health to complete the VAERS form at this time.
pt recv vax 22OCT97 & c/o pain rt arm 27OCT97; returned to hlth unit 3NOV97 w/c/o inc pain;to hlth unit 6NOV97 saw PMD given anti-inflammatory rx;stated may have hit a tendon;
hives underneath her neck; swollen underneath her neck; 3 days after rash she had hives underneath her neck and swollen; Soon after the shot, her arm started going numb, it went to fingers initially to third, fourth and fifth respectively; Sore arm; Fast heart beat; excruciating pain everywhere in her body; Sleeping by 6:30 every evening; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Soon after the shot, her arm started going numb, it went to fingers initially to third, fourth and fifth respectively), PAIN IN EXTREMITY (Sore arm), HEART RATE INCREASED (Fast heart beat), URTICARIA (hives underneath her neck) and SWELLING (swollen underneath her neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced HYPOAESTHESIA (Soon after the shot, her arm started going numb, it went to fingers initially to third, fourth and fifth respectively), PAIN IN EXTREMITY (Sore arm) and HEART RATE INCREASED (Fast heart beat). On 04-Apr-2021, the patient experienced URTICARIA (hives underneath her neck), SWELLING (swollen underneath her neck) and RASH (3 days after rash she had hives underneath her neck and swollen). In April 2021, the patient experienced PAIN (excruciating pain everywhere in her body) and HYPERSOMNIA (Sleeping by 6:30 every evening). The patient was treated with Bed rest for Hypoaesthesia; Bed rest for Pain in extremity and Bed rest for Heart rate increased. On 01-Apr-2021, HYPOAESTHESIA (Soon after the shot, her arm started going numb, it went to fingers initially to third, fourth and fifth respectively) had resolved. In April 2021, PAIN (excruciating pain everywhere in her body) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (Sore arm), HEART RATE INCREASED (Fast heart beat), URTICARIA (hives underneath her neck), SWELLING (swollen underneath her neck), HYPERSOMNIA (Sleeping by 6:30 every evening) and RASH (3 days after rash she had hives underneath her neck and swollen) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Concomitant product use was not provided.  Aside from bed rest, there was no other treatment reported.  The reporter consented for Safety follow up.
after my 2nd dose of the Moderna Vaccine on 5/24, about a week later, I began to have severe pain from my neck to my knees.  I began a regiment of ibuprofen and aleve every day for over a month.  I then made an appointment to see my Dr.   I was referred  immediately to an arthritis dr, who referred me to allergy and immunology, who referred me to infectious disease, who referred me to a neurogologist who gave me the diagnosis of an adverse reaction to the covid vaccine of polymyalgia rheumatica.  I was on prednisone for 3 months.  I had major side effects such as major weight gain, mood swings, fatigue, lack of sleep to name a few.  My primary decided not to put me back on prednisone and to have more blood work done.  I had a second opinion from 2nd MD who suggested I get tested again for Rheumatoid Arthritis, Vasculitis and polymyalgia.   I was referred back to the arthritis dr who did agree with the first tow and came to the conclusion of that I was suffering from polymyalgia.  I didn't want to go back on prednisone and due to the second opinion I suggested hydroxhloroquine to see if that would help.  The arthritis dr didn't think it would work but agreed to give it a try.  He said it could be a month before I see improvement if it works.  I am now into week 2, the pain is now in the ranges of 1-10, prior was definitely at a 10 and now down to an 8.
Upon internal review significant amendment was done on 08-Jan-2018 to add narrative. Initial information received on 29-Nov-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 35 years old female patient who experienced when she touches it she feels pain, while she received vaccine FLUZONE QUADRIVALENT, suspension of injection. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 22-Aug-2018, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot: UI986AB) in the left arm. On an unknown date, the patient developed a non-serious when she touches it she feels pain (vaccination site pain) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Final diagnosis was when she touches it she feels pain. It was not reported if the patient received a corrective treatment. The patient outcome was reported as Unknown for vaccination site pain. List of document held by sender: none. Addendum: 08-Jan-2018. The narrative was added.
With both first vaccine (12/28/20 lot EK9231) and second vaccine (1/21/21), about 12 hours after dose I developed a sore arm, headache, chills, nausea, myalgias, fatigue, sweats. After the first done they resolved approximately 36 hours after the vaccine was administered, or about 24 hours after the symptoms began
Mom called 5/28/0-fever 103.5. No cold sx. No GI sx. Temperature decreased with Ibuprofen. No rash. ER 5/29-fever 104. CBC-nml, UA-nml. BMP-Glu 66. Rocephin/fluids-Home. Seen doctor 5/30, diarrhea 3-4 X day. 5/31-fever 101. Doing better.
Dizziness, Tingling in bilateral hands and feet  BP 148/87, HR 67, RR 16 -- > 140/90, 103.  Pt has a hx of SJS 10yrs ago (did not note cause).  Pt provided crackers and apple juice.  Pt stable and released from vaccination site.  Recommended that the patient follow up with thier healthcare provider and f/u instructions provided.  Pt plans to notify PCP.
Fever the evening of the shot and the next night, sore are at the site of injection for two day Lymph node swelling the next night after the shot in the left arm pit and has subsided as of today but still tender
The day after my 2nd Moderna shot,  my adverse symptoms started. My face started itching, then I developed a red, rash on my face. Also, dark bags under my eyes. The itching and rash symptoms continued for 4 days. I took Benadryl to treat the symptoms. I have photos saved of the rash and dark under eye reaction.
Ringing in ears. Especially noticeable when sitting in a quiet room. Constant low ring when reading or focusing. I'm talking louder at people and it is noticeable to others.
This spontaneous report as received from a healthcare worker refers to unknown number of patients of unknown age. The unknown number of patients had received ZOSTAVAX (lot number not provided) and VARIVAX (lot number not provided) doses which were exposed to -6.8C for 1.5 hours every 24 hours due to defrost cycle every day. No adverse effect reported. It was unspecified if the patients had sought medical attention. The health care professional contacted during telephone follow-up did not remember which patient might have received these vaccines and could not supply the following information: date of birth, dates of vaccination, or lot number. She also stated that the vaccines have been moved to a proper storage unit. Follow-up information received from the healthcare worker. Patient information was updated. On 05-AUG-2013 the patient was vaccinated with a dose of improperly stored ZOSTAVAX (lot#, expiration date and route not reported). Additional information has been requested.
Recvd Td shot 7DEC92; On 4JAN93 pt contacted clinic by phone stating had lt arm pain & weakness every since day of shot; pt was seen that day in clinic, evaluated; no objective evidence of neuromuscular dysfunction clinic; dx tennis elbow
Vaxination durning pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaxination durning pregnancy) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3006324) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaxination durning pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaxination durning pregnancy) had resolved. Not Provided          Concomitant product use was not provided by the reporter. Treatment medication use was not provided by the reporter. grav in hebd 20+0
Skin rash, similar to those of chickenpox for vaccinated people, rashes started around neck area, then arms, waist, legs; Itchy; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 15Apr2021 at 14:45 (at an age of 62-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included high blood pressure, acid reflux and allergy to penicillin and bee sting. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. The patient received other medications (unspecified) within 2 weeks of vaccination. On 18Apr2021, two days after the second vaccination, the patient got skin rash (similar to those of chickenpox for vaccinated people). They still stay there after two weeks, but became less itchy. The rashes started around neck area, then arms, waist and legs. Therapeutic measures were taken as a result of the events with allergy relief over the counter medication(unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of skin rash, similar to those of chickenpox for vaccinated people, rashes started around neck area, then arms, waist, legs and itchy were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window; Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window) and PRODUCT STORAGE ERROR (Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window) and PRODUCT STORAGE ERROR (Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window). On 06-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window) and PRODUCT STORAGE ERROR (Vaccine administered after more than 30 days in the refrigerator/Outside recommended dosing window) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
she got really tired; She started having problems on 12Mar2021 & went to the Emergency Room on 24Mar2021 & was diagnosed with Bells Palsy; he had a severe headache, as well. She said the headache felt like major pressure and pain on the right side of her head, specifically behind her right ear; This is a spontaneous report received from a contactable consumer (patient). A 69-year-old female patient received first dose of BNT162B2 (BNT162B2, Formulation: solution for injection, Lot number - EN6206, expiry date- not reported) via an unspecified route of administration in right arm on 10Mar2021 at 12:00 PM as single dose for COVID-19 immunization. Medical history included ongoing type 1 diabetes mellitus Stated she has had Type 1 Diabetes Mellitus for about 50 years, sleep apnoea syndrome for years, thyroid disorder and influenza immunisation. Concomitant medication(s) included trazodone. On 12mar2021, the patient started having problems on 12mar2021 & went to the emergency room on 24mar2021 & was diagnosed with bells palsy and he had a severe headache. She said the headache felt like major pressure and pain on the right side of her head, specifically behind her right ear and she got really tired. The outcome of bells palsy is recovering whereas the outcome of headache and tired is recovered and unknown respectively. The patient underwent lab tests and procedures which included computerised tomogram: normal on 24Mar2021 and computerised tomogram head: normal on 24Mar2021. Therapeutic measures were taken with events. The patient took Prednisone and Venlafaxine for Bell's palsy and myalgia pain and trazodone taken for sleep apnoea syndrome. The other medication used for events were Valtrex, Tylenol and Acetaminophen.
Patient described having swelling in lymph of right armpit, and the swelling has spread down her trunk on her right side.
Headache, Diarrhea, NauseaVomiting, sore left arm,tingling throat, tired Narrative:
R arm swelling, ubiquitous red itchy rash on entire body, progressively worsening